Milestone Pharmaceuticals (MIST) Insider Trading & Ownership $2.02 +0.02 (+1.00%) Closing price 04:00 PM EasternExtended Trading$2.03 +0.01 (+0.69%) As of 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Milestone Pharmaceuticals (NASDAQ:MIST) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.90%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$13.73 MNumber OfInsiders Selling(Last 3 Years)0 Get MIST Insider Trade Alerts Want to know when executives and insiders are buying or selling Milestone Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MIST Insider Buying and Selling by Quarter Milestone Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/5/2022David BharuchaInsiderBuy7,000$4.69$32,830.00 12/1/2022David BharuchaInsiderBuy3,000$4.86$14,580.00 10/21/2022Debra K LiebertDirectorBuy4,000$5.26$21,040.00 10/19/2022Robert James WillsDirectorBuy15,000$4.93$73,950.00 9/7/2022Rtw Investments, LpMajor ShareholderBuy1,557,346$8.71$13,564,483.66 5/31/2022Paul F TruexDirectorBuy5,000$5.60$28,000.00 (Data available from 1/1/2013 forward) MIST Insider Trading Activity - Frequently Asked Questions Who is on Milestone Pharmaceuticals's Insider Roster? The list of insiders at Milestone Pharmaceuticals includes David Bharucha, Debra K Liebert, Paul F Truex, Robert James Wills, and Rtw Investments, Lp. Learn more on insiders at MIST. What percentage of Milestone Pharmaceuticals stock is owned by insiders? 9.90% of Milestone Pharmaceuticals stock is owned by insiders. Learn more on MIST's insider holdings. Milestone Pharmaceuticals Key ExecutivesMr. Joseph G. Oliveto M.B.A. (Age 56)CEO, President & Director Compensation: $949.47kMr. Amit Hasija (Age 51)CFO & Executive VP of Corporate Development Compensation: $634.89kDr. David B. Bharucha FACC (Age 62)M.D., Ph.D., Chief Medical Officer Compensation: $691.43kDr. Philippe Douville M.B.A. (Age 62)Ph.D., Founder, Strategic Advisor & Member of Scientific Advisory Board Mr. Jeffrey Nelson (Age 43)Chief Operating Officer Ms. Kim FoxVice President of CommunicationsDr. Philip T. Sager FACC (Age 68)FAHA, FHRS, M.D., Chief Medical Advisor & Member of the Scientific Advisory Board Dr. Guy RousseauSVP of Regulatory Affairs and Quality ManagementMs. Anita HolzVP & Head of Medical Affairs More Insider Trading Tools from MarketBeat Related Companies ETON Insider Trades ATXS Insider Trades ANNX Insider Trades ALLO Insider Trades AURA Insider Trades PRME Insider Trades KOD Insider Trades CYRX Insider Trades ESPR Insider Trades CMPX Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:MIST) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIST Stock Alerts